CD4 and neoplasm: However, how PD-1 inhibitor affects the phenotype of CD4+T cells in the immune microenvironment and how CD4+T cells enhance the response of tumor tissues to immune responses are still unclear, and further studies are needed to clarify the cellular biological mechanisms.